The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML. (Q51010350)
Jump to navigation
Jump to search
scientific article published on 8 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML. |
scientific article published on 8 May 2013 |
Statements
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML. (English)
1 reference
1 reference
Gerhard Ehninger
1 reference
Martin Bornhäuser
1 reference
Uwe Platzbecker
1 reference
Johannes Schetelig
1 reference
Christoph Röllig
1 reference
Markus Schaich
1 reference
Study Alliance Leukemia (SAL)
1 reference
Nona Shayegi
1 reference
Caroline Heiderich
1 reference
Michael Kramer
1 reference
Olfert Landt
1 reference
8 May 2013
1 reference
1 reference
122
1 reference
1
1 reference
83-92
1 reference